Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierGlobus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Business segments
Jun 2026 · $789.6MThe company’s own SEC segment disclosure.
- Musculoskeletal Solutions$763.5M97%
- Enabling Technologies$26.1M3%
Globus Medical, Inc. (GMED) reported revenue of $760M in Q1 2026 (quarter ended Mar 31, 2026), up 27% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $124M (16% of revenue). For the full year FY2025, revenue was $2.94B (+17% year on year) and net income $538M. Its largest product in Jun 2026 was Musculoskeletal Solutions at $764M, 97% of the disclosed total, well ahead of Enabling Technologies at 3.3%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Medical Devices
Ranks #1 of 29 by Smart Score